Missing/wrong data?
Log in to edit
Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study.
scientific article
Author/s
author: Josep M. Llovet, Valérie Boige, Jordi Bruix, Thomas Decaens, Philippe Mathurin, Jean-Luc Raoul, Eveline Boucher, Won Young Tak, Joong-Won Park
Work details
Publication date
August 26, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.